NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.60M | 3.60M | 3.82M | 3.61M | 4.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.31M | 8.18M | 8.39M | 8.22M | 9.59M |
| Operating Income | -8.31M | -8.18M | -8.39M | -8.22M | -9.59M |
| Income Before Tax | -8.22M | -8.09M | -8.32M | -8.13M | -9.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.22 | -8.09 | -8.32 | -8.13 | -9.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.22M | -8.09M | -8.32M | -8.13M | -9.47M |
| EBIT | -8.31M | -8.18M | -8.39M | -8.22M | -9.59M |
| EBITDA | -7.78M | -7.62M | -7.78M | -7.54M | -8.85M |
| EPS Basic | -0.41 | -0.44 | -0.48 | -0.51 | -0.63 |
| Normalized Basic EPS | -0.26 | -0.27 | -0.30 | -0.32 | -0.40 |
| EPS Diluted | -0.41 | -0.44 | -0.48 | -0.51 | -0.63 |
| Normalized Diluted EPS | -0.26 | -0.27 | -0.30 | -0.32 | -0.40 |
| Average Basic Shares Outstanding | 80.80M | 74.72M | 69.14M | 63.86M | 60.49M |
| Average Diluted Shares Outstanding | 80.80M | 74.72M | 69.14M | 63.86M | 60.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |